Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib added to tadalafil for erectile dysfunction
IRCT20170417033489N7Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Tadalafil + celecoxib with Tadalafil + placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2020; status: completed.
02
Drugs
celecoxibtadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on IRCT20170417033489N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170417033489N7.